Skip to main content
. 2022 Mar 28;27(7):2192. doi: 10.3390/molecules27072192

Figure 1.

Figure 1

The schematic illustration of experimental design. AOM, G1 (SL) thrice a week from −2 to week 21. G2 mice (10 mg/kg b.w) three times in a week from week 0 to week 6. G3 (low Dose DATSL as 25 mg/kg) three time in a week from week −2 to week 21 + AOM as G2. G4 (High Dose DATSLL as 50 mg/kg) thrice a week from week −2 to week 21 + AOM as G2. G5 (DOXL as 1 mg/kg) three times in a week from week −2 to week 21 + AOM as G2. G6 (Low Dose DATSL as G3 + AOM as G2 + DOXL as G5. G7 (High Dose DATSL as G4 + AOM as G2 + DOXL as G5. G8 (High Dose DATSL as G3 only). G8 (DOXL as G5 only). The mice were given all doses through the intraperitoneal route.